Key result
Guideline-managed oral anticoagulation is not associated with increased perioperative transfusions during lumbar decompression.
Why the study?
The number of patients on chronic oral anticoagulation requiring spine surgery is increasing, yet evidence on the perioperative safety of lumbar decompression remained limited.
Does chronic oral anticoagulation managed with contemporary guideline-based perioperative interruption increase perioperative bleeding or thromboembolic events in patients undergoing microscopic lumbar decompression?
Cohort (n=92)
Does chronic oral anticoagulation managed with contemporary guideline-based perioperative interruption increase perioperative bleeding or thromboembolic events in patients undergoing microscopic lumbar decompression?
Microscopic lumbar decompression can be safely performed without an increase in perioperative bleeding or thromboembolic complications when contemporary guideline-based perioperative oral anticoagulation management is utilized.
Answers are grounded in this paper and cite their sources.
Supports guideline-based anticoagulation management for microscopic lumbar decompression; leaves open confirmation in randomized trials.
Background: The number of patients receiving chronic oral anticoagulation therapy who require spine surgery is increasing. However, evidence regarding the perioperative safety of lumbar decompression remains limited. Methods: We retrospectively reviewed consecutive patients who underwent microscopic lumbar decompression between 2014 and July 2025. Patients receiving antiplatelet therapy alone were excluded. Perioperative anticoagulation management followed current guideline recommendations for high-bleeding-risk surgery. Direct oral anticoagulants were discontinued 36–48 h before surgery according to renal function and resumed after drain removal without heparin bridging. Propensity score matching (1:1) for age, sex, and number of decompressed levels yielded 46 anticoagulated patients (AC group) and 46 controls (N group). Operative time, blood loss, drain output, hemoglobin decrease, transfusion, postoperative hematoma, bleeding complications, and thromboembolic events were compared. Results: There were no significant differences in operative time, estimated blood loss, drain output, or hemoglobin decrease between the groups. Transfusion was rare (6.5% vs. 2.2%, P = 0.617). No patients in the AC group required hematoma evacuation, and no major bleeding complications occurred. No thromboembolic events were observed in either group. Conclusions: Microscopic lumbar decompression may be performed without an apparent increase in perioperative bleeding when contemporary guideline-based perioperative anticoagulation management is followed.
No takes yet. Share an insight, caveat, or question.
Takaoka et al. (2026) conducted a cohort in Lumbar decompression surgery in patients on chronic oral anticoagulation (n=92). Chronic oral anticoagulation managed per high-bleeding-risk guidelines (DOACs discontinued 36-48 h preoperatively without heparin bridging) vs. Matched control patients not receiving anticoagulation was evaluated on Perioperative transfusion (p=0.617). Chronic oral anticoagulation managed per guidelines did not increase perioperative transfusion during microscopic lumbar decompression compared with controls.
Synapse has enriched 10 related papers. Consider them for comparative context: